Expansion of antiviral and antibacterial services and the antiviral and antibacterial space business
First written in FY2020. 9 of 14 entries say "Advanced", first in FY2021-Q1. Latest entry: FY2024-Q1.
Candeal moved to the "Worse" side of this theme in 2024, the same year as the typical company in this theme.
The whole theme swung hardest in 2024: 2 of 7 companies on the "Worse" side.
2 other companies' latest entry also says "Reframed".
- FY2024-Q1ReframedAnnual report
「From the current first-quarter consolidated accounting period, the Company changed the classification so that antiviral and antibacterial services are included in construction services for residential environments.」
The classification was changed so that antiviral and antibacterial services are included in residential building services rather than treated as a separate service category. - FY2023AdvancedAnnual report
「Revenue from antiviral and antibacterial services was ¥453.946 million, equivalent to 231.3% of the prior-year period. The services comprise various coating services for indoor walls and ceilings, wet areas and floors. Revenue increased significantly as wet-area coating projects performed well due to the effects of the capital and business alliance and collaboration with large electronics retailers and others.」
Full-year FY2023 revenue from antiviral and antibacterial services was ¥453.946 million, equivalent to 231.3% of the prior-year period. It states that the capital and business alliance and collaboration with large electronics retailers contributed to higher revenue from wet-area coating projects. - FY2023-Q3AdvancedAnnual report
「Revenue from antiviral and antibacterial services was ¥343.823 million, equivalent to 268.4% of the prior-year period. The services comprise various coating services for indoor walls and ceilings, wet areas and floors. Revenue increased as wet-area coating projects performed well due to the effects of business alliances and collaboration with large electronics retailers and others.」
Cumulative third-quarter revenue from antiviral and antibacterial services was ¥343.823 million, equivalent to 268.4% of the prior-year period. The strong performance of wet-area coating projects resulting from business alliances and collaboration with large electronics retailers and others was reflected in the results. - FY2023-Q2AdvancedAnnual report
「Revenue from antiviral and antibacterial services was ¥217.430 million, equivalent to 269.7% of the prior-year period. The services comprise various coating services for indoor walls and ceilings, wet areas and floors. Revenue increased as wet-area coating projects performed well due to the effects of business alliances and collaboration with large electronics retailers and others.」
Cumulative second-quarter revenue from antiviral and antibacterial services increased to 269.7% of the prior-year period, demonstrating the strong performance of wet-area coating projects resulting from business alliances and collaboration with large electronics retailers and others. - FY2023-Q1AdvancedAnnual report
「Consolidated revenue from antiviral and antibacterial services was ¥84.131 million, equivalent to 203.5% of the prior-year period. The services comprise various coating services for indoor walls and ceilings, wet areas and floors. Revenue increased as projects involving wet-area coatings, undertaken in collaboration with large electronics retailers and others, performed well.」
Cumulative first-quarter revenue from antiviral and antibacterial services increased to 203.5% of the prior-year period. The offerings were specified as various coating services, and wet-area coating projects undertaken in collaboration with large electronics retailers and others performed well. - FY2022Full-year revenue results declinedAnnual report
「Revenue from antiviral and antibacterial services for the current consolidated fiscal year was ¥196.293 million, equivalent to 81.6% of the prior-year period. The services mainly comprise the antiviral and antibacterial coating service “レコナ エアリフレッシュ.”」
The main offerings of the antiviral and antibacterial services remained unchanged, while full-year revenue declined to ¥196.293 million, or 81.6% of the prior-year period. - FY2022-Q3RestatedAnnual report
「Revenue from antiviral and antibacterial services was ¥128.078 million, equivalent to 77.7% of the prior-year period. The services mainly comprise the antiviral and antibacterial coating service “レコナ エアリフレッシュ.”」
The Company disclosed cumulative third-quarter revenue of ¥128.078 million for antiviral and antibacterial services, equivalent to 77.7% of the prior-year period, with coating services identified as the main offering. - FY2022-Q2Decline in sales performanceAnnual report
「Revenue from antiviral and antibacterial services was ¥80.606 million, equivalent to 69.5% of the prior-year period. The services mainly comprise the antiviral and antibacterial coating service “レコナ エアリフレッシュ.”」
Cumulative second-quarter revenue from antiviral and antibacterial services was ¥80.606 million, or 69.5% of the prior-year period. The offering was the antiviral and antibacterial coating service. - FY2022-Q1AdvancedAnnual report
「Revenue from antiviral and antibacterial services was ¥41.341 million, up 14.9% year on year. The services mainly comprise the antiviral and antibacterial coating service “レコナ エアリフレッシュ.”」
Cumulative first-quarter revenue from antiviral and antibacterial services was ¥41.341 million, up 14.9% year on year. The main offering at this stage was the coating service. - FY2021AdvancedAnnual report
「Revenue from antiviral and antibacterial services for the current consolidated fiscal year was ¥240.555 million.」
Antiviral and antibacterial services generated full-year revenue of ¥240.555 million. The Group continued to provide coating services, antibacterial materials and air purifiers. - FY2021-Q3AdvancedAnnual report
「Revenue from antiviral and antibacterial services for the cumulative third quarter of the current consolidated fiscal year was ¥164.892 million, with no year-on-year comparison. The services mainly comprise the antiviral and antibacterial coating service “レコナエアリフレッシュ,” the antiviral and antibacterial material “CA Series,” and the hybrid air purifier “Kirala Air.”」
Antiviral and antibacterial services generated cumulative third-quarter revenue of ¥164.892 million, with the offerings specified as coating services, antibacterial materials and air purifiers. - FY2021-Q2AdvancedAnnual report
「Revenue from antiviral and antibacterial services for the cumulative second quarter of the current consolidated fiscal year was ¥116.049 million, with no year-on-year comparison. The services mainly comprise the antiviral and antibacterial coating service “レコナエアリフレッシュ,” the antiviral and antibacterial material “CA Series,” and the hybrid air purifier “Kirala Air.”」
Antiviral and antibacterial services generated cumulative second-quarter revenue of ¥116.049 million, with the offerings specified as coating services, antibacterial materials and air purifiers. - FY2021-Q1AdvancedAnnual report
「To further expand its antiviral and antibacterial space business, the Group decided to establish a new company, キャンディルパートナーズ. Main businesses: management of distributors and franchise stores handling the Group's services; research, development, manufacturing and sales of antiviral and antibacterial equipment and related products. Capital: ¥50 million. Date of establishment: 2 November 2020. Equity interest: 100% held by the Company.」
On 2 November 2020, 株式会社キャンディルパートナーズ was established and made a consolidated subsidiary to expand the antiviral and antibacterial space business. Research and development, manufacturing and sales of related equipment and products are also included in its business. - FY2020First statedAnnual report
「Our Group moved quickly to strengthen its antiviral and antibacterial business and has provided antiviral and antibacterial spaces to help various companies recover their business performance.」
In response to the spread of COVID-19, the Group developed and strengthened antiviral and antibacterial services as a new service. On 2 November 2020, after the filing, it established the subsidiary キャンディルパートナーズ to conduct research and development, manufacturing and sales of related equipment and products.